Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma

Improving the prognosis and cure rate of HGOSs (high-grade osteosarcomas) is an absolute need. Immune-based treatment approaches have been increasingly taken into consideration, in particular for metastatic, relapsed and refractory HGOS patients, to ameliorate the clinical results currently achieved...

Full description

Bibliographic Details
Main Authors:	Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	International Journal of Molecular Sciences
Subjects:	osteosarcoma prognosis immunotherapeutic target tumor immune microenvironment
Online Access:	https://www.mdpi.com/1422-0067/24/1/799

Similar Items

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
by: Claudia Maria Hattinger, et al.
Published: (2021-06-01)

Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines
by: Chiara Casotti, et al.
Published: (2023-11-01)

Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing
by: Claudia Maria Hattinger, et al.
Published: (2022-10-01)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
by: Massimo Serra, et al.
Published: (2021-09-01)

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
by: Martina Godel, et al.
Published: (2020-06-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
by: Asim Farooq, et al.
Published: (2022-09-01)

ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma
by: Dimas Carolina Belisario, et al.
Published: (2020-03-01)

Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
by: Tao Zhang, et al.
Published: (2020-07-01)

A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma
by: Xiaoyan Zhang, et al.
Published: (2023-07-01)

CD146 is closely associated with the prognosis and molecular features of osteosarcoma: Guidance for personalized clinical treatment
by: Jingkun Wang, et al.
Published: (2022-10-01)

Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
by: Tao Zhang, et al.
Published: (2020-11-01)

Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients
by: Chuan Hu, et al.
Published: (2020-08-01)

A Disulfidptosis-Related Gene Signature Associated with Prognosis and Immune Cell Infiltration in Osteosarcoma
by: Pengyu Chen, et al.
Published: (2023-09-01)

A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
by: Weiguang Yang, et al.
Published: (2022-10-01)

Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma
by: Di Zheng, et al.
Published: (2022-04-01)

Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma
by: Di Zheng, et al.
Published: (2022-10-01)

Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
by: Yiming Zhang, et al.
Published: (2022-06-01)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
by: Claudia Maria Hattinger, et al.
Published: (2020-06-01)

A transmembrane protein family gene signature for overall survival prediction in osteosarcoma
by: Yuehui Du, et al.
Published: (2022-08-01)

Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma
by: Hu Qian, et al.
Published: (2021-04-01)

Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors
by: Katia Scotlandi, et al.
Published: (2020-04-01)

Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma
by: Qizhi Fan, et al.
Published: (2024-04-01)

Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
by: Fengfeng Wu, et al.
Published: (2022-01-01)

Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction
by: Junchao Zhu, et al.
Published: (2023-12-01)

Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis
by: Junfeng Guo, et al.
Published: (2022-04-01)

TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics
by: Zhi-qiang Wei, et al.
Published: (2023-05-01)

Osteosarcoma and Metastasis
by: Gaohong Sheng, et al.
Published: (2021-12-01)

An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma
by: Liyuan Zhang, et al.
Published: (2022-07-01)

Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
by: Prashant Sharma, et al.
Published: (2024-01-01)

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p
by: Dan Yang, et al.
Published: (2023-05-01)

Epigenetics and immune cells in medulloblastoma
by: Francesca Gorini, et al.
Published: (2023-03-01)

Advances in prognostic models for osteosarcoma risk
by: Yi Yao, et al.
Published: (2024-04-01)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
by: Weifeng Hong, et al.
Published: (2020-03-01)

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
by: Iris Chiara Salaroglio, et al.
Published: (2018-06-01)

Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
by: Changwu Wu, et al.
Published: (2024-01-01)

Correlation between the expression of vegf and survival in osteosarcoma
by: André Mathias Baptista, et al.
Published: (2014-10-01)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
by: Yanlin Wu, et al.
Published: (2023-06-01)

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
by: Zhongyue Liu, et al.
Published: (2022-12-01)

Advances in the role of miRNAs in the occurrence and development of osteosarcoma
by: Zhang Guanyu, et al.
Published: (2020-10-01)

Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach
by: Jyotika Varshney, et al.
Published: (2016-01-01)